Skip to main content
VCbacked
Log inGet Started

CHARM Therapeutics

London, United Kingdom

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.

$20.0M raised
Apr 2023
Venture - Series Unknown
Artificial Intelligence (AI)BiotechnologyLife Science

Top Investors

General CatalystKhosla VenturesOrbiMedF-Prime CapitalNVentures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CHARM Therapeutics

How much funding has CHARM Therapeutics raised?
CHARM Therapeutics has raised $20.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2023.
Who are CHARM Therapeutics's investors?
CHARM Therapeutics's investors include General Catalyst, Khosla Ventures, OrbiMed, F-Prime Capital, NVentures.
Where is CHARM Therapeutics headquartered?
CHARM Therapeutics is headquartered in London, United Kingdom.
What does CHARM Therapeutics do?
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
What stage is CHARM Therapeutics at?
CHARM Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"CHARM Therapeutics — Funding & Investors." VCBacked, April 14, 2023, https://www.vcbacked.co/company/charm-therapeutics. Accessed June 3, 2026.
APA
VCBacked. (2023). CHARM Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/charm-therapeutics
Wikipedia (cite web)
{{cite web |title=CHARM Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/charm-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Artificial Intelligence (AI)

View all
Basata
Phoenix
Rokid
Redwood City$1.3M
Tempus
Chicago
Data²
Wilmington$3.0M
Nuro
Mountain View$97.0M
Tekst
Ghent